Merck’s Discounted Zocor Has Had “Negligible Impact,” Teva Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The generic manufacturer has captured over 70% of the generic market for its four strengths of simvastatin.
You may also be interested in...
Teva Launches First Generic Zoloft
Pfizer counters with “authorized” generic through its Greenstone division.
Teva Launches First Generic Zoloft
Pfizer counters with “authorized” generic through its Greenstone division.
Merck Extends Shelf Life Of Branded Zocor Through Rebate Deal With UnitedHealth
Sen. Schumer demands FTC investigation over Merck's alleged "anti-competitive" actions.